This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (University of Oxford/John Cairns via AP)

This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (University of Oxford/John Cairns via AP)

Canada can make vaccines, just not the ones leading the COVID-19 race

Canada has spent more than $1 billion to pre-order seven different developing COVID-19 vaccines

The head of a Canadian biotech industry association says Canada can and does make vaccines — just not the ones expected first to help stop the COVID-19 pandemic.

Prime Minister Justin Trudeau created a firestorm Tuesday when he said Canadians will have to wait a bit to get vaccinated for COVID-19 because the first doses off the production lines will be used in the countries where they are made.

So while vaccinations might start next month in the United States, the United Kingdom and Germany, it will be January at the earliest before any doses are injected in this country.

Canada, said Trudeau, “no longer has any domestic production capacity for vaccines” and it makes sense that the countries that do will prioritize their own citizens.

Andrew Casey, the CEO of BioteCanada, told The Canadian Press Wednesday that Canada does produce vaccines but the technology for the leading COVID-19 vaccine candidates is so new, the manufacturing capacity is being built alongside the vaccines themselves.

“This is the first time the technology has actually been applied,” he said. “So you have to then build the facility to manufacture at scale, which is a challenge.”

While pharmaceutical company Sanofi has a vaccine plant in Toronto and GlaxoSmithKline has one in Quebec, both make protein-based vaccines, such as the more familiar ones Canadians get every year for the flu.

Canada has spent more than $1 billion to pre-order seven different developing COVID-19 vaccines, and only one being developed jointly by Sanofi and GlaxoSmithKline uses the protein technology.

The first two vaccines expected on the market, from Pfizer and Moderna, each use genetic material known as messenger ribonucleic acid or mRNA. A third with promising trial results, from AstraZeneca, uses a modified common-cold virus that normally infects chimpanzees. Each type trains the human body to develop antibodies to SARS-CoV-2, the virus that causes COVID-19.

Casey said a protein-vaccine maker can’t just start making the bioengineered vaccines.

“One is like making wine, one’s like making Coke,” he said. “Yes, they both grow in bottles. Yes, you can drink both out of a glass. But the manufacturing processes used for the two is so completely different. You can’t just say well, we’ll shut down the protein one, and we’ll switch over to the mRNA.”

READ MORE: Canada’s inability to manufacture vaccines in-house will delay distribution: Trudeau

Conservative health critic Michelle Rempel Garner demanded in question period Wednesday that the government explain whether Canada had even tried to convince the companies to make their products here.

Trudeau didn’t answer, but if those negotiations happened, they have not been successful.

Pfizer is expanding production facilities in Kalamazoo, Mich. and Puurs, Belgium to produce most of its vaccine. The company has said it is open to others manufacturing it, but that the technology is difficult to transfer.

Moderna has a 10-year exclusive agreement with Swiss-based Lonza Group AC to make its vaccine, mainly in facilities in New Hampshire and Switzerland. Lonza chairman Albert Baehny said earlier this month the new technology meant Lonza had to remake its production lines “from scratch.”

AstraZeneca, which has promised three billion doses of its vaccine, has signed contract deals with at least two dozen manufacturers around the world to produce its vaccine but not in Canada.

A spokesman for Innovation Minister Navdeep Bains said the biomanufacturing sector has been declining in Canada since the mid-1980s.

“When this pandemic began Canada had no flexible, large-scale, bio-manufacturing capacity suitable for a COVID-19 vaccine,” said John Power.

He said Canada has been working with experts to address the issue and has made investments, including $140 million in a new National Research Council plant in Montreal.

The NRC said Wednesday the Biologics Manufacturing Centre will be finished next July. It doesn’t have an agreement yet to produce a specific vaccine, but is being built so it can produce several biologic vaccines, including of the type being made by AstraZeneca. It will not be able to make mRNA vaccines like those from Moderna or Pfizer.

It is supposed to be able to produce two million doses a month before the end of 2021.

A spokeswoman for GlaxoSmithKline told The Canadian Press the company’s Ste-Foy, Que., plant will be part of production of the GSK vaccine eventually but timelines and specifics aren’t yet available.

A Canadian-made vaccine from Quebec-based Medicago is also expected to be in production in Canada next year.

Medicago CEO Bruce Clark said the company has been able to adapt a vaccine for influenza to target COVID-19 instead, noting such an adaptation is one of the advantages of biologic vaccines. But Clark said one of the disadvantages is that it’s harder to transfer the technology of biologics to be made in other places.

Medicago has facilities in Quebec and North Carolina and is building a new one in Quebec. The existing ones can make about 50 million doses by the end of next year, while the new plant will be able to do as many as a billion annually.

The company has been talking to the federal government for years to get funding for a “full-scale manufacturing facility,” he said.

“We were not successful,” said Clark. “It’s really only been in the context of the pandemic that we’ve seen funds be freed up to commit to capacity in Canada.”

Last month Ottawa agreed to provide $173 million to Medicago for research on its vaccine and construction of an expanded facility. Clark said the 2023 completion date for the new plant could be bumped up with more money.

None of the vaccines in question have finished clinical trials and all must also be approved by Health Canada before they can be used here.

Mia Rabson, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Corsac the cat is up for adoption at Critteraid.
Critteraid hosts three adoption Sundays

More than 40 cats looking for their forever homes

Abigail McCluskey is in the Netherlands training to compete in the World Cup next month. She joins 12 Canadian speedskaters for the international competition later this month. (Dave Holland CSI Calgary)
Penticton speed skater in Netherlands for World Cup

Abigail McCluskey will be skating the long track in the international competition

Summerland Middle School
COVID exposure at Summerland Middle School

The person who tested positive was at school Jan. 11

Justin Kripps of Summerland and his team have competed in Olympic action and World Cup competitions in bobsleigh. (Jason Ransom-Canadian Olympic Comittee).
QUIZ: Are you ready for some winter sports?

It’s cold outside, but there are plenty of recreation opportunities in the winter months

A map released by the BCCDC on Jan. 15 shows the number of new COVID-19 cases reported for each local health area between Jan. 3 and 9. (BCCDC Image)
Salmon Arm and Vernon see increase in new COVID cases, curve flattening elsewhere

The rate of new cases is levelling off in Kelowna, Penticton and Revelstoke.

A scene from “Canada and the Gulf War: In their own words,” a video by The Memory Project, a program of Historica Canada, is shown in this undated illustration. THE CANADIAN PRESS/HO - Historica Canada
New video marks Canada’s contributions to first Gulf War on 30th anniversary

Veterans Affairs Canada says around 4,500 Canadian military personnel served during the war

Vernon’s Heron Grove retirement facility. (Good Samaritan Society photo)
Resident of Vernon’s Heron Grove retirement home tests positive for COVID-19

Interior Health has not declared an outbreak at the facility

A 17-year-old snowmobiler used his backcountry survival sense in preparation to spend the night on the mountain near 100 Mile House Saturday, Jan. 16, 2021 after getting lost. (South Cariboo Search and Rescue Facebook photo)
Teen praised for backcountry survival skills after getting lost in B.C.’s Cariboo mountains

“This young man did everything right after things went wrong.”

Conservative Leader Erin O’Toole holds a press conference on Parliament Hill, in Ottawa on December 10, 2020. THE CANADIAN PRESS/Sean Kilpatrick
No place for ‘far right’ in Conservative Party, Erin O’Toole says

O’Toole condemned the Capitol attack as ‘horrifying’ and sought to distance himself and the Tories from Trumpism

A passer by walks in High Park, in Toronto, Thursday, Jan. 14, 2021. This workweek will kick off with what’s fabled to be the most depressing day of the year, during one of the darkest eras in recent history. THE CANADIAN PRESS/Chris Young
‘Blue Monday’ getting you down? Exercise may be the cure, say experts

Many jurisdictions are tightening restrictions to curb soaring COVID-19 case counts

(Vernon Search and Rescue/Facebook)
Vernon Search and Rescue responds after family gets UTV stuck on SilverStar trails

The family activated their SOS beacon around 3 p.m. once they realized they could be facing a night alone in the mountains

Dastkar, a new furniture store in Vernon, features handmade, unique furniture carved from wood and inlaid with brass in the Chiniot style. The business located on 43rd Avenue was started in December 2020 but is currently unstaffed due to COVID-19 staffing shortages. (Brendan Shykora - Morning Star)
PHOTOS: Vernon’s hidden handmade furniture store

Owners of Shahi Pakwan Indian restaurant opened the South Asian furniture store in December 2020

A health-care worker prepares a dose of the Pfizer-BioNTech COVID-19 vaccine at a UHN COVID-19 vaccine clinic in Toronto on Thursday, January 7, 2021. THE CANADIAN PRESS/Nathan Denette
COVID-19: Provinces work on revised plans as Pfizer-BioNTech shipments to slow down

Anita Anand said she understands and shares Canadians’ concerns about the drug company’s decision

Tourists take photographs outside the British Columbia Legislature in Victoria, B.C., on Friday August 26, 2011. A coalition of British Columbia tourism industry groups is urging the provincial government to not pursue plans to ban domestic travel to fight the spread of COVID-19. THE CANADIAN PRESS/Darryl Dyck
B.C. travel ban will harm struggling tourism sector, says industry coalition

B.C. government would have to show evidence a travel ban is necessary

Most Read